Alphamab Oncology

About:

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

Website: http://www.alphamabonc.com

Top Investors: OrbiMed, Janchor Partners, PAG, Hudson Bay Capital Management, Heritage Provider Network

Description:

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.

Total Funding Amount:

$160M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2009-01-01

Contact Email:

hr(AT)alphamabonc.com

Founders:

Xu Ting

Number of Employees:

251-500

Last Funding Date:

2019-05-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai